[Long-term results and perspectives of various radio-endovascular embolization in the treatment of patients with renal parenchyma cancer].
Various types of x-ray endovascular embolization were carried out in 256 patients with renal parenchymatous carcinoma over the period of 1979 to 1991. Iodolipol chemoembolization with dioxadet, a fat-soluble preparation, significantly improved three- and five-year cumulative survival of operable patients to 82.5 and 77%, respectively, vs. embolization without dioxadet, when only 58% of patients survived for three and 51% for five years. In inoperable patients five-year survival after fatty chemoembolization was 24.5% vs. null in the group administered embolization without dioxadet. Ferrochemoembolization appears still more promising.
Granov
A M
AM
Anisimov
V N
VN
Karelin
M I
MI
Zakharov
A Iu
AIu
Shumskiĭ
I A
IA
D000970:Antineoplastic Agents / Q000008:administration & dosage; D017609:Barium Compounds / Q000008:administration & dosage*; D016461:Chemoembolization, Therapeutic; D005500:Follow-Up Studies; D006801:Humans; D007459:Iodized Oil / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D015642:Radiology, Interventional; D015996:Survival Rate; D013997:Time Factors; D014227:Triazines / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D017609:Barium Compounds; D014227:Triazines; C035791:barium hexaferrite; D007459:Iodized Oil; C040269:dioxadet
Otdalennye rezultaty i perspektivy razlichnykh vidov rentgenoéndovaskuliarnoĭ émbolizatsii v lechenii bolńykh rakom parenkhimy pochki.